BPI-9016M
BPI-9016M is a potent, orally active, and selective dual c-Met and AXL tyrosine kinases inhibitor. BPI-9016M suppresses tumor cell growth, migration and invasion of lung adenocarcinoma[1][2].
Product Specifications
CAS Number
1528546-94-2
Product Name Alternative
Trimethoprim 3-N-oxide
UNSPSC
12352005
Target
C-Met/HGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bpi-9016m.html
Purity
97.13
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=CNC=C(C2=CC=C(F)C=C2)C1=O)NC3=CC=C(OC4=C5C(NCC5)=NC=C4)C(F)=C3
Molecular Formula
C25H18F2N4O3
Molecular Weight
460.43
References & Citations
[1]Zhang P, et al. BPI-9016M, a c-Met inhibitor, suppresses tumor cell growth, migration and invasion of lung adenocarcinoma via miR203-DKK1. Theranostics. 2018 Nov 12;8 (21) :5890-5902.|[2]Hu X, et al. First-in-human phase I study of BPI-9016M, a dual MET/Axl inhibitor, in patients with non-small cell lung cancer.J Hematol Oncol. 2020 Jan 16;13 (1) :6.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15097534 1 Vial
Lentiviral human SLC39A8 shRNA (UAS) - Lentiviral human SLC39A8 shRNA (UAS, GFP) plasmid
Sign In for Pricing
View Details 
150241 100 µg
CENTA1 (Arf-GAP with Dual PH Domain-containing Protein 1, Centaurin-alpha-1, Cnt-a1, ADAP1, Putative MAPK-activating Protein PM25) discontinued
Sign In for Pricing
View Details